|
US2006188974A1
|
|
Human protein kinases and protein kinase-like enzymes
|
|
US2006204994A1
|
|
Novel human protein kinases and protein kinase-like enzymes
|
|
US2006216730A1
|
|
Novel human protein kinases and protein kinase-like enzymes
|
|
BRPI0510032A
|
|
Thiophene heteroaryl amines
|
|
WO2005113561A1
|
|
Cyclicsulfonate pyrrole indolinones as kinase inhibitors
|
|
WO2005111234A2
|
|
Methods of using zc1 and zc3 kinase substrate phosphorylation as biomarkers
|
|
BRPI0507834A
|
|
method for treating abnormal cell growth using c-met and m-tor inhibitors
|
|
EP1653946A2
|
|
Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein kinase inhibitors
|
|
US2005014755A1
|
|
Tetracyclic compounds as c-Met inhibitors
|
|
MXPA06000276A
|
|
Indolinone hydrazides as c-met inhibitors.
|
|
BRPI0412207A
|
|
triazolotriazine compounds and uses thereof
|
|
BRPI0412003A
|
|
arylmethyl triazole and imidazopyrazines as c-met inhibitors
|
|
US2005075340A1
|
|
Triazolotriazine compounds and uses thereof
|
|
US2005009832A1
|
|
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
|
US2005125852A1
|
|
Novel kinases
|
|
US2005084877A1
|
|
Mammalian protein phosphatases
|
|
US2004204407A1
|
|
5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
|
|
US2004266843A1
|
|
Sulfonamide substituted indolinones as inhibitors of DNA dependent protein kinase (DNA-PK)
|
|
BRPI0407827A
|
|
Aminoeteroaryl compounds as protein kinase inhibitors and their uses
|
|
UA80474C2
|
|
Aminoheteroaryl compounds as inhibitors of protein kinase
|
